Edgar Dippel
Klinikum Ludwigshafen · 239 works · 4,578 citations · h-index 34
Top works
- Alternative versus Classical Activation of Macrophages
- Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”
- A heterotrimeric G protein complex couples the muscarinic m1 receptor to phospholipase C-beta.
- Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
- Clonal T-cell receptor ?-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation
- High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing
- Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes
- Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)
- Extracorporeal photopheresis and interferon-α in advanced cutaneous T-cell lymphoma
- Clonal T cell receptor γ‐chain gene rearrangement by PCR‐based GeneScan analysis in the skin and blood of patients with parapsoriasis and early‐stage mycosis fungoides
- Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis
- Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome
- Expression of the c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo
- Comparative Cytokine Release from Human Monocytes, Monocyte-Derived Immature Mast Cells, and a Human Mast Cell Line (HMC-1)
- Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
- Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
- Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study
- Jessner’s Lymphocytic Infiltration of the Skin: A CD8+ Polyclonal Reactive Skin Condition
- S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version
- Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial